Search - tctmd.com

Displaying 441 - 460 of 465

Sort: Relevancy | Date

News Industry News

CardiAQ™ Valve Technologies Reports Cardiovascular Medicine Milestone: First-in-Human Nonsurgical Percutaneous Implantation of a Bioprosthetic Mitral Heart Valve

June 14, 2012

News Industry News

Cardiosolutions, Inc. Receives FDA 510(k) Clearance for Dexterity™ Steerable Introducer

June 13, 2012

News Industry News

St. Jude Medical Launches New Trifecta Heart Valve in Japan

April 17, 2012

News Daily News

Un Estudio Investiga el Impacto de la RM Moderada o Severa sobre Pacientes sometidos a TAVR

Jason Kahn

April 06, 2012

News Daily News

Study Investigates Impact of Moderate or Severe MR in TAVR Patients

Jason Kahn

April 06, 2012

News Conference News ACC 2012

Study Looks at Long-term Mortality Predictors in TAVR Patients

Jason Kahn

March 27, 2012

News Industry News

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

March 20, 2012

News Daily News

Experts Give Their Picks for Most Important Developments of 2011

Jason Kahn

March 08, 2012

News Daily News

Mitral Repair Can Augment Heart Function in CABG Patients

Caitlin E. Cox

March 04, 2012

News Daily News

Interventional Issues Featured in AHA/ASA ‘Top 10’ Research Reports of 2011

February 07, 2012

News Daily News

Early Percutaneous Intervention May Help Asymptomatic Mitral Stenosis

Caitlin E. Cox

January 17, 2012

News Daily News

EVEREST II Registry Looks at MitraClip in High-Risk Patients

Jason Kahn

January 04, 2012

News Conference News

Mitral Regurgitation Surgical Repair Rates, Durability Continue to Improve

November 07, 2011

News Industry News

Abbott to Present New Data for Key Vascular Products at TCT 2011

November 03, 2011

News Daily News

CoreValve Appears a Feasible Replacement for Failed Surgical Aortic Valves

October 03, 2011

News Industry News

St. Jude Medical Announces FDA Approval of Trifecta Valve

April 20, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

News Industry News

On-X Heart Valve PROACT Trial Preliminary Report Provides Evidence Toward Maintaining Patients With Less Warfarin

April 05, 2011

News Conference News

EVEREST II: Two-Year Outcomes Show Positive, Negative Aspects of MitraClip

April 04, 2011

News Industry News

Data from Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients with Mitral Regurgitation Two Years After Treatment

April 04, 2011

Advertisement

CardiAQ™ Valve Technologies Reports Cardiovascular Medicine Milestone: First-in-Human Nonsurgical Percutaneous Implantation of a Bioprosthetic Mitral Heart Valve

Cardiosolutions, Inc. Receives FDA 510(k) Clearance for Dexterity™ Steerable Introducer

St. Jude Medical Launches New Trifecta Heart Valve in Japan

Un Estudio Investiga el Impacto de la RM Moderada o Severa sobre Pacientes sometidos a TAVR

Study Investigates Impact of Moderate or Severe MR in TAVR Patients

Study Looks at Long-term Mortality Predictors in TAVR Patients

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

Experts Give Their Picks for Most Important Developments of 2011

Mitral Repair Can Augment Heart Function in CABG Patients

Interventional Issues Featured in AHA/ASA ‘Top 10’ Research Reports of 2011

Early Percutaneous Intervention May Help Asymptomatic Mitral Stenosis

EVEREST II Registry Looks at MitraClip in High-Risk Patients

Mitral Regurgitation Surgical Repair Rates, Durability Continue to Improve

Abbott to Present New Data for Key Vascular Products at TCT 2011

CoreValve Appears a Feasible Replacement for Failed Surgical Aortic Valves

St. Jude Medical Announces FDA Approval of Trifecta Valve

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

On-X Heart Valve PROACT Trial Preliminary Report Provides Evidence Toward Maintaining Patients With Less Warfarin

EVEREST II: Two-Year Outcomes Show Positive, Negative Aspects of MitraClip

Data from Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients with Mitral Regurgitation Two Years After Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content